Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutational and co-mutational landscape of early onset colorectal cancer.
Alshenaifi JY, Vetere G, Maddalena G, Yousef M, White MG, Shen JP, Vilar E, Parseghian C, Dasari A, Morris VK, Huey R, Overman MJ, Wolff R, Raghav KP, Willis J, Alfaro K, Futreal A, You YN, Kopetz S. Alshenaifi JY, et al. Among authors: futreal a. Biomarkers. 2025 Jan 9:1-13. doi: 10.1080/1354750X.2024.2447089. Online ahead of print. Biomarkers. 2025. PMID: 39761813
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer.
Wang X, Zhao L, Song X, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Coffer LW 2nd, Alexander A, Vines A, Bopparaju S, Woodward WA, Chu R, Zhang J, Yam C, Loo LWM, Nasrazadani A, Huong LP, Woodman SE, Futreal A; Rare Tumor Initiative Team; Tripathy D, Ueno NT. Wang X, et al. Among authors: futreal a. NPJ Precis Oncol. 2024 Nov 18;8(1):265. doi: 10.1038/s41698-024-00729-0. NPJ Precis Oncol. 2024. PMID: 39558017 Free PMC article.
Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response.
Cheng X, Dai E, Wu J, Flores NM, Chu Y, Wang R, Dang M, Xu Z, Han G, Liu Y, Chatterjee D, Hu C, Ying J, Du Y, Yang L, Guan X, Mo S, Cao X, Pei G, Jiang J, Lu X, Benitez AM, Waters RE, Pizzi MP, Shanbhag N, Fan Y, Peng F, Hanash SM, Calin G, Futreal A, Song S, Yee C, Mazur PK, Qin JJ, Ajani JA, Wang L. Cheng X, et al. Among authors: futreal a. Gastroenterology. 2024 Dec;167(7):1345-1357. doi: 10.1053/j.gastro.2024.07.038. Epub 2024 Aug 2. Gastroenterology. 2024. PMID: 39097198
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study.
de Sousa LG, Liu S, Bhosale P, Altan M, Darbonne W, Schulze K, Dervin S, Yun C, Mahvash A, Verma A, Futreal A, Gite S, Cuentas EP, Cho WC, Wistuba I, Yao JC, Woodman SE, Halperin DM, Ferrarotto R. de Sousa LG, et al. Among authors: futreal a. Oral Oncol. 2024 Apr;151:106747. doi: 10.1016/j.oraloncology.2024.106747. Epub 2024 Mar 8. Oral Oncol. 2024. PMID: 38460288 No abstract available.
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.
Almekinders MM, Bismeijer T, Kumar T, Yang F, Thijssen B, van der Linden R, van Rooijen C, Vonk S, Sun B, Parra Cuentas ER, Wistuba II, Krishnamurthy S, Visser LL, Seignette IM, Hofland I, Sanders J, Broeks A, Love JK, Menegaz B, Wessels L, Thompson AM, de Visser KE, Hooijberg E, Lips E, Futreal A, Wesseling J; Grand Challenge PRECISION Consortium. Almekinders MM, et al. Among authors: futreal a. Br J Cancer. 2022 Oct;127(7):1201-1213. doi: 10.1038/s41416-022-01888-2. Epub 2022 Jun 29. Br J Cancer. 2022. PMID: 35768550 Free PMC article.
Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.
Manzar GS, Alam MBE, Lynn EJ, Karpinets TV, Harris T, Lo D, Yoshida-Court K, Napravnik TC, Sammouri J, Lin D, Andring LM, Bronk J, Wu X, Sims TT, Mathew G, Schmeler KM, Eifel PJ, Jhingran A, Lin LL, Joyner MM, Zhang J, Futreal A, Klopp AH, Colbert LE. Manzar GS, et al. Among authors: futreal a. Brachytherapy. 2024 Mar-Apr;23(2):123-135. doi: 10.1016/j.brachy.2023.10.007. Epub 2023 Dec 20. Brachytherapy. 2024. PMID: 38129211
Conquering Overtreatment of DCIS: Lessons from PRECISION.
Bhattacharjee P, Lips EH, Sawyer EJ, Hwang ES, Thompson AM, Wesseling J; Cancer Grand Challenges PRECISION Consortium. Bhattacharjee P, et al. Cancer Discov. 2025 Jan 13;15(1):28-33. doi: 10.1158/2159-8290.CD-24-1201. Cancer Discov. 2025. PMID: 39801240
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma.
Goswami S, Gao J, Basu S, Shapiro DD, Karam JA, Tidwell RS, Ahrar K, Campbell MT, Shen Y, Trevino AE, Mayer AT, Espejo AB, Seua C, Macaluso MD, Chen Y, Liu W, He Z, Yadav SS, Wang Y, Rao P, Zhao L, Zhang J, Jindal S, Futreal A, Wang L, Tannir NM, Sharma P. Goswami S, et al. Among authors: futreal a. Res Sq [Preprint]. 2024 Nov 12:rs.3.rs-4331053. doi: 10.21203/rs.3.rs-4331053/v1. Res Sq. 2024. PMID: 39606482 Free PMC article. Preprint.
Correction: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.
Yoshida-Court K, Karpinets TV, Mitra A, Solley TN, Dorta-Estremera S, Sims TT, Delgado Medrano AY, Alam MBE, Ahmed-Kaddar M, Lynn EJ, Sastry KJ, Zhang J, Futreal A, Nick A, Lu K, Colbert LE, Klopp AH. Yoshida-Court K, et al. Among authors: futreal a. PLoS One. 2024 Nov 22;19(11):e0314643. doi: 10.1371/journal.pone.0314643. eCollection 2024. PLoS One. 2024. PMID: 39576772 Free PMC article.
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial.
Cabanillas ME, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang JR, Lu C, Ning M, McKinley BA, Woodman SE, Duose D, Gunn GB, Busaidy NL; Rare Tumor Initiative Team. Cabanillas ME, et al. JAMA Oncol. 2024 Dec 1;10(12):1672-1680. doi: 10.1001/jamaoncol.2024.4729. JAMA Oncol. 2024. PMID: 39446377 Free PMC article. Clinical Trial.
166 results